AI negli ambienti GxP: ciò che ogni responsabile IT farmaceutico deve sapere
In questo webinar, il Dr. Ajaz Hussain, ex Deputy Director della U.S. FDA, spiega cosa è realmente necessario per implementare l'AI in modo responsabile nelle operazioni farmaceutiche regolamentate.
With over three decades of experience spanning machine learning research, FDA policy development, and pharmaceutical quality systems, Dr. Hussain brings rare, first-hand authority to one of the most pressing questions facing pharma IT leaders today.
📌 What This Session Covers:
54% of pharma companies have no AI in GxP.
ML, GenAI, and Agentic AI are not the same thing in GxP, and confusing them could cost billions.
Most companies are stuck in compliance theater.
FDA issued a warning letter for AI-generated drug specs.
Before deploying AI in GxP, can you prove your people, processes, and products are stable?
_____________________________
Disclaimer: The views and opinions expressed in this episode are solely those of the guest and do not necessarily reflect the official policy or position of Pharma Now or any organisation they are affiliated with. This conversation is intended for informational and educational purposes only. We are here for honest, unfiltered conversations that move the industry forward.
I relatori
Ricevi un invito nel calendario appena viene annunciato un webcast.
Una breve email per sessione — titolo, relatori e un clic per aggiungerlo al calendario.Nothing else.